Two Sigma Advisers’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
KCM
RHJA
PHP
MHP
Two Sigma Advisers's OPRX Position: Q3 2025 in Review
Two Sigma Advisers sold out of OptimizeRx (OPRX) in Q3 2025, closing a stake of 23,023 shares — an estimated $311K sold.
Two Sigma Advisers first reported a position in OPRX in Q4 2020 and held it in 15 quarters. The position peaked at $10.1M in Q2 2021. 125 funds tracked by Wall St. Rank hold OPRX as of Q3 2025.
- Two Sigma Advisers reported no remaining OptimizeRx position as of Q3 2025 after selling out during the quarter.
- Two Sigma Advisers sold 23,023 OptimizeRx shares in Q3 2025, an estimated $311K.
- Two Sigma Advisers first reported a position in OptimizeRx in Q4 2020 and held it in 15 quarters.
- Two Sigma Advisers's OptimizeRx position peaked at $10.1M in Q2 2021.
- 125 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2025.
Based on Two Sigma Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.